Incidence and outcomes of bepridil-induced interstitial pneumonia-Reference-Cited by-同舟云学术

Incidence and outcomes of bepridil-induced interstitial pneumonia

Published:2013-12 Issue:12 Volume:107 Page:2088-2091
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Yamasaki Kei,Yatera Kazuhiro,Noguchi Shingo,Oda Keishi,Akata Kentarou,Nishida Chinatsu,Kawanami Toshinori,Kawanami Yukiko,Ishimoto Hiroshi,Ono Shiro,Wakuta Yukio,Mukae Hiroshi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference12 articles.

1. A case of bepridil induced interstitial pneumonitis;Gaku;Heart,2003

2. Gradual progression of interstitial pneumonia induced by bepridil;Suzuki;Intern Med,2009

3. Two patients with bepridil-induced interstitial pneumonia;Watanabe;Circ J,2009

4. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I);Martin;Chest,1988

5. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial;Yamase;Heart,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VII. Management of Nursing and Healthcare-associated Pneumonia;Nihon Naika Gakkai Zasshi;2021-06-10

2. Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease;PLOS ONE;2019-10-04

3. A simple and sensitive LC-MS/MS method for quantification of Bepridil in rat plasma and its application to pharmacokinetic studies;Journal of Pharmaceutical and Biomedical Analysis;2019-08

4. Drug-Induced Interstitial Lung Disease: A Systematic Review;Journal of Clinical Medicine;2018-10-15

5. DLI Induced by Antiarrhythmic Drug and Antimicrobial Drug: What Are the Characteristics of DLI in Antiarrhythmic Drugs and Antimicrobial Drugs?;Respiratory Disease Series: Diagnostic Tools and Disease Managements;2017-06-30